Dyadic International DYAI
NASDAQ DYAI
$0.69 -0.01 (-1.74%)
As of: Aug 21, 2026 · 11:40 AM EDT

Dyadic International (DYAI) Total Current Liabilities (2017 - 2026)

Dyadic International (DYAI) posted Total Current Liabilities of $3.2 million for Q1 2026, down 13.65% sequentially from $3.7 million in Q4 2025, and up 62.26% YoY from $2.0 million in Q1 2025.

Dyadic International (DYAI) Total Current Liabilities (2017 - 2026) Analysis & Trends

Dyadic International has reported Total Current Liabilities for 10 years, with the latest figure at $3.2 million in Q1 2026.

  • Quarterly Total Current Liabilities rose 62.26% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (up 62.26% YoY) and the FY2025 annual result came in at $3.7 million, up 50.62% from the prior year.
  • Total Current Liabilities eased to $3.2 million in Q1 2026 per DYAI's latest filing, from $3.7 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $1.8 billion in Q1 2022 and troughed at $1.5 million in Q3 2023.
  • A 5-year average of $109.9 million and a median of $2.4 million in 2022 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2022 and 2023: Total Current Liabilities jumped 70319.08% in 2022, then slumped 99.9% in 2023.
  • Over 5 years, Total Current Liabilities stood at $2.4 million in 2022, then decreased by 8.04% to $2.3 million in 2023, then increased by 8.71% to $2.4 million in 2024, then jumped by 50.62% to $3.7 million in 2025, then fell by 13.65% to $3.2 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $3.2 million, $3.7 million, and $4.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 139.95 Bn 132.10 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 86.71 Bn 78.72 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 65.71 Bn 60.52 Bn 1.37 Bn 1.58 Bn
4 Moderna 60.45 Bn 55.31 Bn 52.00 Mn 2.53 Bn
5 BeOne Medicines 42.24 Bn 37.14 Bn 1.53 Bn 2.12 Bn
6 Alnylam Pharmaceuticals 31.80 Bn 28.49 Bn 992.69 Mn 1.51 Bn
7 BioNTech SE 28.64 Bn 10.25 Bn 668.28 Mn 2.49 Bn
8 Insmed 27.61 Bn 26.45 Bn 358.27 Mn 438.74 Mn
9 Royalty Pharma 27.26 Bn 26.42 Bn - 630.93 Mn
10 Dyadic International 19.83 Mn 19.83 Mn - 3.18 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.18 Mn
Dec 31, 2025 3.69 Mn
Sep 30, 2025 4.05 Mn
Jun 30, 2025 3.66 Mn
Mar 31, 2025 1.96 Mn
Dec 31, 2024 2.45 Mn
Sep 30, 2024 2.08 Mn
Jun 30, 2024 1.95 Mn
Mar 31, 2024 2.26 Mn
Dec 31, 2023 2.25 Mn
Sep 30, 2023 1.46 Mn
Jun 30, 2023 2.00 Mn
Mar 31, 2023 1.88 Mn
Dec 31, 2022 2.45 Mn
Sep 30, 2022 2.39 Mn
Jun 30, 2022 3.40 Mn
Mar 31, 2022 1.83 Bn
Dec 31, 2021 2.56 Mn
Sep 30, 2021 1.96 Mn
Jun 30, 2021 3.29 Mn